TNF and rheumatoid arthritis: Accordingly, clinical trials on TNF blockers [197], IL-1 [198], and IL-6 receptor blockage [199,200] gave evidence of the impact of inflammation on osteoclastogenesis by retarding or inhibiting bone erosion in RA patients.